Drug intelligence / Profile preview

PulmoLAR

Development stage
Unknown
Lead developer
Pulmonary Research Partners
Modality
Small Molecules
Administration
Subcutaneous
01

Overview

PulmoLAR is a proprietary sustained-release injectable formulation of 2-methoxyestradiol (2ME) being developed by Pulmonary Research Partners (PRP) for the treatment of pulmonary arterial hypertension (PAH). 2-methoxyestradiol is an endogenous metabolite of estradiol that lacks significant estrogenic activity but possesses potent anti-proliferative, anti-angiogenic, and anti-inflammatory properties. In the context of PAH, 2ME is thought to inhibit the remodeling of pulmonary arteries by suppressing the proliferation of pulmonary artery smooth muscle cells and fibroblasts, likely through the inhibition of hypoxia-inducible factor 1-alpha (HIF-1α) and the disruption of microtubule dynamics. PulmoLAR is administered as a subcutaneous injection and is designed to provide sustained therapeutic levels of 2ME, aiming to improve safety and efficacy over immediate-release or oral alternatives.

Brand names
PulmoLAR
Other names
2-methoxyestradiol sustained-release injection2-ME2-ME2

Beyond the preview

Go deeper on PulmoLAR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PulmoLAR.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call